Literature DB >> 2334184

Prognostic factors and predictive signs of malignancy in adult dermatomyositis. A study of 32 cases.

N Basset-Seguin1, J C Roujeau, R Gherardi, J C Guillaume, J Revuz, R Touraine.   

Abstract

Dermatomyositis (DM) is an inflammatory myopathy with a severe prognosis mainly determined by its association with malignancy. We present the results of a study of 32 adults with DM. Our aim was to define predictive signs of cancer and establish prognostic factors according to patient survival. Thirteen (41%) of the 32 patients had DM associated with malignancy. After 7 years of follow-up, the overall mortality rate was 52%. Mortality was higher for patients with malignancy. Cutaneous necrosis and an elevated erythrocyte sedimentation rate appeared as potential markers of associated malignancy. Classic signs of poor prognosis, such as age and association with cancer were found. Interestingly, extensive cutaneous lesions on the trunk and an elevated erythrocyte sedimentation rate were also more frequent among the patients who died. Our results demonstrate that selected groups of patients with DM, in part defined by cutaneous signs, have a poor prognosis.

Entities:  

Mesh:

Year:  1990        PMID: 2334184

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  18 in total

Review 1.  Polymyositis/dermatomyositis: the current position.

Authors:  A Urbano-Márquez; J Casademont; J M Grau
Journal:  Ann Rheum Dis       Date:  1991-03       Impact factor: 19.103

2.  Prognosis and mortality of polymyositis and dermatomyositis patients.

Authors:  A Airio; H Kautiainen; M Hakala
Journal:  Clin Rheumatol       Date:  2006-02-14       Impact factor: 2.980

Review 3.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

Review 4.  Cutaneous manifestations of cancer and chemotherapy.

Authors:  Emma Topham
Journal:  Clin Med (Lond)       Date:  2009-08       Impact factor: 2.659

5.  A case of erythrodermic dermatomyositis associated with gastric cancer.

Authors:  Sung Woo Kim; Yoo Seok Kang; Sang Hoon Park; Un Ha Lee; Hyun Su Park; Sang Jai Jang
Journal:  Ann Dermatol       Date:  2009-11-30       Impact factor: 1.444

6.  Dermatomyositis: analysis of 109 patients surveyed at the Hospital das Clínicas (HCFMUSP), São Paulo, Brazil.

Authors:  Luciena Cegatto Martins Ortigosa; Vitor Manuel Silva dos Reis
Journal:  An Bras Dermatol       Date:  2014 Sep-Oct       Impact factor: 1.896

Review 7.  Paraneoplastic rheumatic syndromes.

Authors:  Csilla András; Zoltán Csiki; Andrea Ponyi; Arpád Illés; Katalin Dankó
Journal:  Rheumatol Int       Date:  2005-08-10       Impact factor: 2.631

Review 8.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 9.  Paraneoplastic dermatological manifestation of gastrointestinal malignancies.

Authors:  Lyubomir A Dourmishev; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-09-21       Impact factor: 5.742

10.  Polymyositis and vaginal carcinoma.

Authors:  G Cormio; G Di Vagno; G Loverro; L Selvaggi
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.